Third degree AV block screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(10 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Third degree AV block}}
{{Third degree AV block}}
{{CMG}}; {{AE}} {{Soroush}}
{{CMG}}; {{AE}} {{Sara.Zand}} {{Soroush}} {{ADG}}
==Overview==
==Overview==


There is insufficient evidence to recommend routine screening for [disease/malignancy].  
[[Ambulatory electrocardiographic monitoring]] is useful for finding intermittent  [[atrioventricular block]], [[LBBB]] and [[bifascicular block]] in [[asymptomatic]] [[patients]]. In [[patients]] with [[symptomatic]] [[atrioventricular block]] or [[bradycardia]] during [[sleep]], screening about [[sleep apnea]] is recommended.


OR
According to the [guideline name], screening for third degree AV block is not recommended.
OR
According to the [guideline name], screening for third degree AV block by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
==Screening==
==Screening==
There is insufficient evidence to recommend routine screening for [disease/malignancy].
*[[Ambulatory electrocardiographic monitoring]] is useful for finding intermittent  [[atrioventricular block]], [[LBBB]] and [[bifascicular block]] in [[asymptomatic]] [[patients]].
 
* In [[patients]] with [[symptomatic]] [[atrioventricular block]] or [[bradycardia]] during [[sleep]], screening about [[sleep apnea]] is recommended.<ref name="KasaiFloras2012">{{cite journal|last1=Kasai|first1=Takatoshi|last2=Floras|first2=John S.|last3=Bradley|first3=T. Douglas|title=Sleep Apnea and Cardiovascular Disease|journal=Circulation|volume=126|issue=12|year=2012|pages=1495–1510|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.111.070813}}</ref>
OR
* Screening for [[congenital]] [[complete heart block]] is recommended in [[pregnant]] [[women]] with Ro/SSA [[antibodies]].<ref name="pmid30137589">{{cite journal| author=Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E et al.| title=The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices. | journal=Rheumatology (Oxford) | year= 2018 | volume= 57 | issue= suppl_5 | pages= v9-v17 | pmid=30137589 | doi=10.1093/rheumatology/key141 | pmc=6099126 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30137589  }}</ref>
*[[Women]] with [[history]] of [[neonatal lupus]], [[fetal]] echos are recommended weekly or every other week from week 18 to 28.
* It is unclear how often [[first degree heart block]] progresses to [[complete heart block]], some cases my revert to [[normal sinus rhythm]] or [[complete heart block]].


According to the [guideline name], screening for third degree AV block is not recommended.


OR


According to the [guideline name], screening for third degree AV block by [test 1] is recommended every [duration] among patients with:
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
*[Condition 1]
|-
*[Condition 2]
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF;" align=center |'''Recommendations for screening  sleep apnea in patients with bradycardia or conduction disorder
*[Condition 3]
|-
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''  ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]]):'''
|-
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left|
❑  Screening about [[sleep apnea syndrome]] is recommended In [[patients]] with documented or suspected [[bradycardia]] or [[conduction]] disorder during [[sleep]]<br>
❑ [[Continuous airway pressure]] and [[weight loss]] is recommended in [[patients]] with [[bradycardia]] or [[conduction]] disorder during [[sleep]] and documented [[obstructive sleep apnea]]<br>
|-
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''  ([[ACC AHA guidelines classification scheme|Class IIa, Level of Evidence B]]):'''
|-
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left|
❑ In [[patients]] with previously [[PPM]] implantation for [[bradycardia]] or [[conduction disorder]], screening about [[sleep apnea syndrome]] is reasonable<br> 
<br>
|}
{|
! colspan="2" style="background: PapayaWhip;" align="center" + |The above table adopted from 2018 AHA/ACC/HRS Guideline<ref name="KusumotoSchoenfeld2019">{{cite journal|last1=Kusumoto|first1=Fred M.|last2=Schoenfeld|first2=Mark H.|last3=Barrett|first3=Coletta|last4=Edgerton|first4=James R.|last5=Ellenbogen|first5=Kenneth A.|last6=Gold|first6=Michael R.|last7=Goldschlager|first7=Nora F.|last8=Hamilton|first8=Robert M.|last9=Joglar|first9=José A.|last10=Kim|first10=Robert J.|last11=Lee|first11=Richard|last12=Marine|first12=Joseph E.|last13=McLeod|first13=Christopher J.|last14=Oken|first14=Keith R.|last15=Patton|first15=Kristen K.|last16=Pellegrini|first16=Cara N.|last17=Selzman|first17=Kimberly A.|last18=Thompson|first18=Annemarie|last19=Varosy|first19=Paul D.|title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society|journal=Circulation|volume=140|issue=8|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000628}}</ref>
|-
|}


==References==
==References==

Latest revision as of 07:58, 24 July 2021

Third degree AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Third degree AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Third degree AV block screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Third degree AV block screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Third degree AV block screening

CDC on Third degree AV block screening

Third degree AV block screening in the news

Blogs on Third degree AV block screening

Directions to Hospitals Treating Third degree AV block

Risk calculators and risk factors for Third degree AV block screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Soroush Seifirad, M.D.[3] Aditya Ganti M.B.B.S. [4]

Overview

Ambulatory electrocardiographic monitoring is useful for finding intermittent atrioventricular block, LBBB and bifascicular block in asymptomatic patients. In patients with symptomatic atrioventricular block or bradycardia during sleep, screening about sleep apnea is recommended.

Screening


Recommendations for screening sleep apnea in patients with bradycardia or conduction disorder
(Class I, Level of Evidence B):

❑ Screening about sleep apnea syndrome is recommended In patients with documented or suspected bradycardia or conduction disorder during sleep
Continuous airway pressure and weight loss is recommended in patients with bradycardia or conduction disorder during sleep and documented obstructive sleep apnea

(Class IIa, Level of Evidence B):

❑ In patients with previously PPM implantation for bradycardia or conduction disorder, screening about sleep apnea syndrome is reasonable

The above table adopted from 2018 AHA/ACC/HRS Guideline[3]

References

  1. Kasai, Takatoshi; Floras, John S.; Bradley, T. Douglas (2012). "Sleep Apnea and Cardiovascular Disease". Circulation. 126 (12): 1495–1510. doi:10.1161/CIRCULATIONAHA.111.070813. ISSN 0009-7322.
  2. Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E; et al. (2018). "The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices". Rheumatology (Oxford). 57 (suppl_5): v9–v17. doi:10.1093/rheumatology/key141. PMC 6099126. PMID 30137589.
  3. Kusumoto, Fred M.; Schoenfeld, Mark H.; Barrett, Coletta; Edgerton, James R.; Ellenbogen, Kenneth A.; Gold, Michael R.; Goldschlager, Nora F.; Hamilton, Robert M.; Joglar, José A.; Kim, Robert J.; Lee, Richard; Marine, Joseph E.; McLeod, Christopher J.; Oken, Keith R.; Patton, Kristen K.; Pellegrini, Cara N.; Selzman, Kimberly A.; Thompson, Annemarie; Varosy, Paul D. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". Circulation. 140 (8). doi:10.1161/CIR.0000000000000628. ISSN 0009-7322.

Template:WH Template:WS